| Elizabeth Brooke Railsback, OTR | |
|
5225 S Loop 289 # 2, Lubbock, TX 79424-1363 | |
| (806) 780-4180 | |
| Not Available |
| Full Name | Elizabeth Brooke Railsback |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 5225 S Loop 289 # 2, Lubbock, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073123949 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 120984 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Brooke Railsback, OTR 5220 Spring Valley Rd Ste 400, Dallas, TX 75254-2512 Ph: (214) 466-1340 | Elizabeth Brooke Railsback, OTR 5225 S Loop 289 # 2, Lubbock, TX 79424-1363 Ph: (806) 780-4180 |
News Archive
Among patients with the lung disorder non-cystic fibrosis bronchiectasis, treatment with the antibiotic erythromycin resulted in improvement in symptoms but also increased the risk of antibiotic resistance, according to a study appearing in the March 27 issue of JAMA.
Research published in the American Journal of Gastroenterology shows that an exclusion diet combined with medical treatment can increase healing rates in patients with chronic anal fissure who have been referred for surgery.
Each day in the United States, 482 people are diagnosed with a brain tumor. For these 482 people, not many treatments exist. With the current treatments available, only 5% of those diagnosed with a Glioblastoma Multiform will survive more than 5 years. Only two new treatments have been approved by the FDA in the past two decades.
Relypsa, Inc., today announced the initiation of patient enrollment in a Phase 2, open-label titration clinical study of the company's lead drug candidate, RLY5016, in heart failure patients with chronic kidney disease. RLY5016 is a novel non-absorbed oral potassium binder intended to prevent and treat hyperkalemia, a serious condition characterized by elevated serum potassium levels.
Current government programmes aimed at reducing drug and alcohol use among young people may be ineffective and may even be doing more harm than good, according to a paper published today in Public Policy Research, the quarterly journal published today by the Institute for Public Policy Research.
› Verified 8 days ago
Maureen Castellano, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3510 4th Street, Lubbock, TX 79415 Phone: 806-472-3400 | |
Jana Torres, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3501 S. Loop 289, Lubbock, TX 79414 Phone: 806-796-1774 Fax: 806-796-1714 | |
John Phillip Jackson, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7810 Avenue U Apt B, Lubbock, TX 79423 Phone: 806-778-9735 | |
Mr. Randy Michael Moore, O.T.R. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3114 105th St, Lubbock, TX 79423 Phone: 806-368-7759 | |
Bailee Elaine Bunnell, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3107 19th St, Lubbock, TX 79410 Phone: 325-669-6531 | |
Morgan Rees, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2401 20th St, Lubbock, TX 79411 Phone: 806-750-4180 Fax: 817-789-6849 | |
Justine Davis/kitten, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3501 S. Loop 289, Lubbock, TX 79414 Phone: 806-796-1774 Fax: 806-796-1714 |